Scope Biosciences Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$2.27M
- Investors
-
8
Scope Biosciences General Information
Description
Operator of a molecular diagnostics technology designed to enable accessible nucleic acid detection in healthcare and agriculture. The company's technology offers specificity in detecting single-nucleotide differences, sensitivity to trace genetic material, and a format operable outside laboratory settings, enabling healthcare providers and agricultural professionals to make on-site decisions.
Contact Information
Website
www.scopebio.comCorporate Office
- Bronland 12B-1
- 6708 WH Wageningen
- Netherlands
Corporate Office
- Bronland 12B-1
- 6708 WH Wageningen
- Netherlands
Scope Biosciences Timeline
Scope Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Seed Round | 16-Jun-2025 | $2.27M | Completed | Generating Revenue | ||
| 7. Seed Round | 24-Oct-2023 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 5. Corporate | 29-Oct-2021 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | Completed | Startup | ||||
| 3. Accelerator/Incubator | 01-Jan-2020 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2019 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2020 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Scope Biosciences Patents
Scope Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3987058-A1 | Type iii crispr/cas-based diagnostics | Active | 19-Jun-2019 | ||
| EP-3987058-B1 | Type iii crispr/cas-based diagnostics | Active | 19-Jun-2019 | ||
| EP-3987058-C0 | Type iii crispr/cas-based diagnostics | Active | 19-Jun-2019 | ||
| EP-4497833-A2 | Type iii crispr/cas-based diagnostics | Active | 19-Jun-2019 | ||
| EP-4497833-A3 | Type iii crispr/cas-based diagnostics | Active | 19-Jun-2019 | C12Q1/6823 |
Scope Biosciences Signals
Scope Biosciences Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Oost NL | Venture Capital | Minority | ||
| SHIFT Invest | Venture Capital | Minority | ||
| StartLife | Accelerator/Incubator | |||
| GenDx | Corporation | Minority | ||
| LifeSciences@Work | Accelerator/Incubator |
Scope Biosciences FAQs
-
When was Scope Biosciences founded?
Scope Biosciences was founded in 2020.
-
Where is Scope Biosciences headquartered?
Scope Biosciences is headquartered in Wageningen, Netherlands.
-
What is the size of Scope Biosciences?
Scope Biosciences has 12 total employees.
-
What industry is Scope Biosciences in?
Scope Biosciences’s primary industry is Biotechnology.
-
Is Scope Biosciences a private or public company?
Scope Biosciences is a Private company.
-
What is Scope Biosciences’s current revenue?
The current revenue for Scope Biosciences is .
-
How much funding has Scope Biosciences raised over time?
Scope Biosciences has raised $3.96M.
-
Who are Scope Biosciences’s investors?
Oost NL, SHIFT Invest, StartLife, GenDx, and LifeSciences@Work are 5 of 8 investors who have invested in Scope Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process